Diagnosis and Clinical Genetics of Cushing Syndrome in Pediatrics.
Constantine A Stratakis
https://pubmed.ncbi.nlm.nih.gov/27241967Actively Recruiting
Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2026-06-01
600
Participants Needed
1
Research Sites
N/A
Total Duration
Cushing Disease (CD) is caused by pituitary tumors that produce excess cortisol, leading to various health problems. This research focuses on understanding the long-term effects of high cortisol levels experienced during childhood and adolescence, especially after the disease has been treated and cortisol levels have normalized. The study aims to clarify complications like hormone imbalances, metabolic issues, and neurocognitive effects that may persist or develop over time in those who had pediatric CD. Participants include individuals diagnosed and successfully treated for pediatric CD before age 21, who now have normal or low cortisol levels. Family members of these patients may also join for genetic studies. The study involves regular evaluations at 5, 10, 15, and 20 years after cure, including online surveys and optional in-person visits with physical exams, blood tests, imaging scans like DXA and MRI, and neurocognitive assessments. Additional tests such as hormone stimulation and urine collection may be done for participants with the disease. During the study, participants complete medical history reviews, questionnaires about physical and mental health, and undergo clinical assessments to monitor body mass index and other health measures. Researchers track changes in endocrine function, bone density, metabolism, cardiovascular health, immune system, and quality of life over time. The study includes ongoing safety monitoring and may last up to 20 years to provide long-term insights into the effects of pediatric Cushing Disease and guide future care.
CONDITIONS
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - Up to 20 years after documented cure, with assessments at 5, 10, 15, and 20 years (+/-1 year)
Participants previously treated for pediatric Cushing Disease are observed at specific intervals to assess their health status over time, including medical diagnoses, endocrine function, neurocognitive function, and quality of life.
Online surveys and optional on-site short visits at NIH offered at each assessment interval
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
D
Deborah P Merke, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Constantine A Stratakis
https://pubmed.ncbi.nlm.nih.gov/27241967J H Davies, H L Storr, K Davies...
https://pubmed.ncbi.nlm.nih.gov/15807878Margaret F Keil, Jennifer Graf, Nirmal Gokarn...
https://pubmed.ncbi.nlm.nih.gov/22154461